Skip to main content
. 2020 Aug 24;58(9):e00311-20. doi: 10.1128/JCM.00311-20

TABLE 6.

Performance of the FilmArray ME panel for positive targets with and without the testing algorithma

Result category No. of specimens with result/total no. of specimens tested (%)
Without testing algorithm With testing algorithm (repeat testing for all positive targets) With revised testing algorithm (selective repeat testing)b
All targets (n = 45)
    TP reported 41/41 (100) 38/41 (92.7) 41/41 (100)
    FP reported 4/4 (100) 1/4 (25) 1/4 (25)
    FP avoided 0/4 (0) 3/4 (75) 3/4 (75)
    PPV 41/45 (91.1) 38/39 (97.4) 41/42 (97.6)
    FN generated NA 3c /41 (7.3) 0c /41
Viral targets (n = 33)
    TP reported 33/33 (100) 31/33 (93.9) 33/33 (100)
    FP reported 0/0 (0) 0/0 (0) 0/0 (0)
    FP avoided NA NA NA
    PPV 33/33 (100) 31/31 (100) 33/33 (100)
    FN generated NA 2/33 (6.1) 0/33
Nonviral targets (n = 12)
    TP reported 8/8 (100) 7/8 (87.5) 8/8 (100)
    FP reported 4/4 (100) 1/4 (25) 1/4 (25)
    FP avoided 0/4 (0) 3/4 (75) 3/4 (75)
    PPV 8/12 (66.7) 7/8 (87.5) 8/9 (88.9)
    FN generated NA 1c /8 (12.5) 0c /8 (0)
a

The reference result was based on concurrent conventional test results and clinical adjudication. Only those targets with concurrent conventional test results and that were successfully worked up per the testing algorithm were included in this analysis. TP, true positive; FP, false positive; PPV, positive predictive value; NA, not applicable.

b

Repeat testing only for bacterial targets with a negative Gram stain result and the C. neoformans/C. gattii target with negative Gram stain, calcofluor white, and CrAg test results. There was no repeat testing for positive viral targets.

c

One false-negative C. neoformans/C. gattii result was avoidable because it had a positive CrAg test result. Therefore, it was reported as a true positive in the revised testing algorithm.